Oklahoma City, OK, United States of America

Mariko Kudo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genzyme Glycobiology Research Institute Inc.. Active years: 2005.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mariko Kudo: Innovator in Glycobiology

Introduction

Mariko Kudo is a prominent inventor based in Oklahoma City, OK (US). She has made significant contributions to the field of glycobiology, particularly through her innovative research and patents. Her work focuses on the development of biochemical methods that have the potential to impact various applications in medicine and biotechnology.

Latest Patents

Mariko Kudo holds a patent for a soluble GlcNAc phosphotransferase. This invention relates to a method of making the soluble GlcNAc phosphotransferase and a method of phosphorylating using the same. This patent showcases her expertise and dedication to advancing scientific knowledge in her field. She has 1 patent to her name.

Career Highlights

Kudo is affiliated with the Genzyme Glycobiology Research Institute Inc., where she continues to push the boundaries of research in glycobiology. Her work has been instrumental in developing new methodologies that enhance our understanding of glycan biology and its implications in health and disease.

Collaborations

Mariko collaborates with various professionals in her field, including her coworker William M Canfield. These collaborations foster an environment of innovation and knowledge sharing, which is essential for advancing research in glycobiology.

Conclusion

Mariko Kudo is a trailblazer in the field of glycobiology, with her innovative patent and contributions to research. Her work exemplifies the impact that dedicated inventors can have on science and technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…